Annual report pursuant to Section 13 and 15(d)

STOCK COMPENSATION PLANS (Details)

v2.4.0.8
STOCK COMPENSATION PLANS (Details) (USD $)
In Millions, except Share data, unless otherwise specified
 12 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
CCE's North American business
Dec. 31, 2013
Stock Options
Dec. 31, 2013
1999 Option Plan
Dec. 31, 2013
2002 Option Plan
Dec. 31, 2013
2008 Option Plan
Dec. 31, 2013
Stock options granted in December 2003 and thereafter
Dec. 31, 2013
Stock options granted from 1999 through July 2003
Dec. 31, 2013
Performance share units
Dec. 31, 2012
Performance share units
Dec. 31, 2011
Performance share units
Dec. 31, 2013
Performance share units
2011-2013 Performace Period
Dec. 31, 2013
Performance share units
2012 to 2014 Performance Period
Dec. 31, 2013
Performance share units
Performance Period 2013 to 2015 [Member]
Dec. 31, 2010
Performance share units
CCE's North American business
Dec. 31, 2013
Performance share units
CCE's North American business
Dec. 31, 2012
Performance share units
CCE's North American business
Dec. 31, 2011
Performance share units
CCE's North American business
Oct. 02, 2010
Performance share units
CCE's North American business
Dec. 31, 1989
1989 Restricted Stock Award Plan
Dec. 31, 1983
1983 Restricted Stock Award Plan
Dec. 31, 2013
Time-Based Restricted Stock Unit Awards
Dec. 31, 2013
Time-Based Restricted Stock Unit Awards
CCE's North American business
Dec. 31, 2013
Performance-based Restricted Stock Unit Awards
Dec. 31, 2013
Restricted stock award plan [Member]
Dec. 31, 2012
Restricted stock award plan [Member]
Dec. 31, 2011
Restricted stock award plan [Member]
STOCK COMPENSATION PLANS [Abstract]                                                          
Total stock-based compensation expense $ 227 $ 259 $ 354                                                    
Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements 62 72 99                                                    
Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted 416                                                        
Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years) 1 year 9 months 11 days                                                        
Stock-based compensation awards                                                          
Share-based Compensation Arrangement by Share-based Payment Award Performance Share Unit Projected Payout Percentage                                         200.00%                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage                                                   150.00%      
Vesting period of stock-based awards (in years)       3 years 4 years                                                
Weighted-average assumptions used in the Black Scholes Merton option pricing model                                                          
Fair value of options at grant date (in dollars per share) $ 3.73 $ 3.80 $ 4.64                                                    
Dividend yield (as a percent) 2.80% 2.70% 2.70%                                                    
Expected volatility (as a percent) 17.00% 18.00% 19.00%                                                    
Risk-free interest rate (as a percent) 0.90% 1.00% 2.30%                                                    
Expected term of the option (in years) 5 years 5 years 5 years                                                    
Share-based compensation disclosure                                                          
Common stock was approved to be issued or transferred through the grant of stock options (in shares)           240,000,000 240,000,000 280,000,000                                          
Granted (in shares) 56,000,000                                                        
Exercised (in shares) (53,000,000) (61,000,000) (65,000,000)                                                    
Forfeited/expired (in shares) (7,000,000)                                                        
Outstanding on December 31 (in shares) 305,000,000 309,000,000   3,000,000                                                  
Expected to vest at December 31, 2013 302,000,000                                                        
Granted, Weighted-Average Exercise Price (in dollars per share) $ 37.68                                                        
Exercised, Weighted-Average Exercise Price (in dollars per share) $ 25.02                                                        
Forfeited/expired, Weighted-Average Exercise Price (in dollars per share) $ 34.34                                                        
Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share) $ 29.42 $ 27.27   $ 18.02                                                  
Expected to vest at December 31, 2013, Weighted-Average Exercise Price (in dollars per share) $ 29.33                                                        
Expected to Vest, Weighted Average Remaining Contractual Life (in years) 5 years 9 months 11 days                                                        
Outstanding on December 31, 2013, Weighted-Average Remaining Contractual Life (in years) P5Y9M26D                                                        
Exercisable on December 31, 2013, Weighted-Average Remaining Contractual Life (in years) 4 years 3 months                                                        
Outstanding on December 31, 2013, Aggregate Intrinsic Value (in dollars) 3,636                                                        
Expected to vest at December 31, 2013, Aggregate Intrinsic Value (in dollars) 3,614                                                        
Exercisable on December 31, 2013 187,000,000                                                        
Exercisable on December 31, 2013, Aggregate Intrinsic Value (in dollars) 2,887                                                        
Expiration period of stock-based awards (in years)       10 years         10 15 years                                      
Total intrinsic value of options exercised 815 780 631                                                    
Number of Shares Available for Grant (in shares) 84,000,000     29,000,000                         3,800,000         80,000,000 48,000,000       25,000,000    
Summary disclosures                                                          
Paid in cash equivalent (in shares) (54,999)                   (55,000) (16,267) (19,462)                                
Canceled/forfeited (in shares)                     (760,000)                               (508,000)    
Outstanding on December 31 (in shares)                     17,974,000 17,584,000                                  
Granted                     6,425,000                                    
Outstanding on January 1, 2013, Weighted-Average Grant-Date Fair Value (in dollars per share)                     $ 28.01                               $ 26.54    
Paid in cash equivalent, Weighted-Average Grant-Date Fair Value (in dollars per share)                     $ 32.25                                    
Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share)                     $ 30.33                               $ 25.17    
Outstanding on December 31, 2013, Weighted-Average Grant-Date Fair Value (in dollars per share)                     $ 30.41 $ 28.01                             $ 25.17 $ 26.54  
Restricted shares units vested and released (in shares) (405,963)                                                   (406,000) (4,301,732) (2,084,912)
Vested and released, Weighted-Average Grant-Date Fair Value (in dollars per share)                                                     $ 25.52    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period                                 3,300,000                        
Number of shares issued due to modification in the performance awards                                   100,000 600,000 3,100,000                  
Intrinsic value of shares issued due to modification in the performance awards                                   5 22 98                  
Outstanding performance share units at the Threshold Award Level (in shares) 9,000,000                                                        
Outstanding performance share units at the Maximum Award Level (in shares) 27,000,000                                                        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value                     $ 32.67 $ 29.95 $ 25.58       $ 29.56                        
Restricted shares vested and released under performance share unit awards, total intrinsic value                                                     16 148 72
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 years                                                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards, Granted before 2008 2 years                                                        
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards Granted 2008 and beyond 1 year                                                        
Exercisable on December 31, 2013 weighted average exercise price (in dollars per share) $ 25.87                                                        
Performance share units outstanding based on the target award amounts (in shares)                           5,365,000 6,487,000 6,122,000               700,000 59,000 81,000 7,014,000 98,000  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted in Restricted Stock Units in Period                     (5,220,000)                               (7,830,000)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted in Restricted Stock in Period, Weighted Average Grant Date Fair Value                     $ 25.17                               $ 25.17    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other-than-Options Paid in Cash Equivalent in Period Value $ 1.8 $ 0.6 $ 0.7